In a blog post last summer, we asked what appeared to be a simple question: Is value-based care a fad? It turns out that while the question may be simple, the answer is a bit more complicated.
After the blog post ran, we heard from the Dell Medical School at the University of Texas, Austin. The school has a department devoted to teaching value-based care to its medical students. AHCJ will host a webcast at noon ET on Tuesday, June 25, for members featuring two of the school’s professors — Elizabeth Teisberg, Ph.D., and Scott Wallace — who will answer questions about value-based care and explain what students in this program are learning. Continue reading
Investigative journalist Katherine Eban will discuss her new book documenting rampant fraud in the generic drug industry during an AHCJ webcast on Wednesday, June 19.
In her book, “Bottle of Lies: The Inside Story of the Generic Drug Boom,” Eban reveals how generic drug makers not only help ensure that some of the worst quality drugs enter the least regulated markets but also take extreme measures to avoid regulatory scrutiny. Harper Collins/Ecco’s Hardcover division published the book on May 14. Continue reading
In September, Yen Duong, Ph.D., had just started work for North Carolina Health News when Hurricane Florence was churning up the east coast.
Duong’s assignment was to cover health care in Charlotte. Being three hours inland from the coast turned out to be somewhat fortuitous for Duong who had just started her second journalism job after a summer at the Raleigh News & Observer as a mass media fellow for the American Association for the Advancement of Science. Continue reading
One question Julie Appleby posed to a panel she moderated on the high cost of prescription drugs was simple enough: Do drug pricing reform efforts promise consumer relief?
The answer from three experts Appleby assembled for a panel discussion at Health Journalism 2019 this month in Baltimore was that, yes, efforts in Congress could provide some relief and those efforts have bipartisan support. But, as with any pending legislation, the details in the final bills will matter. Also, of course, any bill needs to pass both houses and then President Trump would need to sign it. Continue reading
Photo: Pia Christensen/AHCJMartin Van Trieste
One of the best sessions at Health Journalism 2019 in Baltimore was the panel discussion about drug prices on May 3, “Of price spikes and shortages: New initiatives to increase patient access to generic and biosimilar drugs.” Wendy Wolfson, an independent journalist from Irvine, Calif., moderated the discussion.
Perhaps the most interesting of the four panel members was Martin Van Trieste, president and CEO, Civica Rx, a nonprofit manufacturer of generic drugs for hospitalized patients. Seven of the nation’s largest health systems have invested in Civica and their representatives will serve on its board of directors along with representatives from three philanthropies: the Laura and John Arnold Foundation, the Peterson Center on Healthcare, and the Gary and Mary West Foundation. Continue reading
At some point almost all health care journalists will need to cover a medical study or two. When that happens, you’ll want to have at least a passing understanding of p values and statistics and you’ll need to know that correlation does not imply causation.
For a session on May 2, AHCJ’s medical studies topic leader Tara Haelle moderated a panel, “Begin mastering medical studies.” Haelle and two experts in the topic explained some of the finer points of covering studies: Ishani Ganguli, M.D., an assistant professor of medicine at the Harvard Medical School, and an internal medicine physician at Brigham and Women’s Hospital; and Regina Nuzzo, Ph.D., a freelance journalist and professor of science, technology and mathematics at Gallaudet University. Continue reading